Deciphera Pharmaceuticals, Inc. (DCPH)

Last Three Months

24-Jan-24 -- 23-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

7

0

5

+1

0

+2

0

+3

Two Year Chart

24-Apr-22 -- 23-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
20-Feb-24 4:05 PM View:	16-Feb-24 Sale ($47.01K)	Kelly Thomas Patrick Chief Financial Officer		Deciphera Pharmaceuticals, Inc. - DCPH	22% 66.08K to 80.35K	0	0	--	--	Show Txns Hide Txns

09-Feb-24 4:30 PM View:	07-Feb-24 Exercise (in-the money or at-the-money) $9.14K	Brightstar Associates LLC 10% Owner		Deciphera Pharmaceuticals, Inc. - DCPH	4% 22.15M to 23.06M	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:05 PM View:	16-Feb-24 Sale ($35.41K)	Martin Daniel C. Chief Commercial Officer		Deciphera Pharmaceuticals, Inc. - DCPH	16% 47.66K to 55.12K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:06 PM View:	16-Feb-24 Sale ($40.84K)	Sherman Matthew L EVP & Chief Medical Officer		Deciphera Pharmaceuticals, Inc. - DCPH	16% 94.08K to 108.74K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:05 PM View:	15-Feb-24 Grant 0	Dhanak Dashyant EVP & Chief Scientific Officer		Deciphera Pharmaceuticals, Inc. - DCPH	12% 140.9K to 158.18K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:05 PM View:	16-Feb-24 Sale ($35.41K)	Pitman Jama SVP, Chief Development Officer		Deciphera Pharmaceuticals, Inc. - DCPH	35% 50.57K to 68.03K	0	0	--	--	Show Txns Hide Txns